BiomarkersHumans
Combining p ‐tau217 with Other Blood Biomarkers to Enhance Prediction of Cognitive Decline: A Large Memory Clinic Cohort Study
AAIC 2025 Abstract
Abstract
Background: Plasma p ‐tau217 has emerged as one of the most promising biomarkers for Alzheimer's disease (AD). However, it remains largely unexplored whether integrating p ‐tau217 with other emerging AD blood biomarkers (BBMs) will enhance its clinical performance.
The paper
Monika Renuka Sanotra, Xuemei Zeng, Rebecca A. Deek, Thomas K. Karikari
Show 22 more authors
Jeremy M. Gu, Marissa F. Farinas, Michel N Nafash, Lamia Choity, Tara K Lafferty, Annie Bedison, Rocco B Mercurio, Cristy Matan, Julia Kofler, Dana Tudorascu, C. Elizabeth Shaaban, Jennifer Hagerty Lingler, Tharick Ali Pascoal, William E. Klunk, Victor L. Villemagne, Sarah B. Berman, Robert A. Sweet, Beth Ellen Snitz, Miloš D. Ikonomović, Ann D. Cohen, M. Ilyas Kamboh, Oscar L. López,University of Pittsburgh
AAIC 2025 Abstract · 8 Jan 2026 · CC BY
Presented at AAIC 2025
